Famotidine for oral suspension is a histamine-2 (H) receptor antagonist indicated (1):
In adults for the treatment of:
· active duodenal ulcer (DU).
· active gastric ulcer (GU).
· symptomatic nonerosive gastroesophageal reflux disease (GERD).
· erosive esophagitis due to GERD, diagnosed by biopsy.
· treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias).
· reduction of the risk of DU recurrence.
In pediatric patients 1 year of age and older for the treatment of:
· peptic ulcer
· GERD with or without esophagitis and ulcerations
In pediatric patients from birth to less than 1 year of age for the treatment of:
· GERD.